The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

A non-surgical sleeve refers to procedures that mimic the effects of sleeve gastrectomy but without surgery. One such method is the Endoscopic Sleeve Gastroplasty (ESG), which reduces stomach size using sutures inserted through an endoscope. This approach is less invasive, has a faster recovery time, and is typically used for patients who do not qualify for surgical interventions.

The "Slimming Pen" refers to injectable medications like Saxenda and Wegovy (semaglutide) that help with weight loss. These medications regulate hunger hormones, helping users feel fuller and eat less. They are prescribed for individuals who need additional support in managing their weight, especially when diet and exercise alone aren’t sufficient. They’re increasingly popular in the UK, with potential NHS coverage for certain patients.

A GI malignancy refers to any cancerous growth within the gastrointestinal tract. These cancers are often aggressive and can spread quickly if not detected early. Colon cancer, stomach cancer, and pancreatic cancer are common forms of GI malignancy. Gastroenterologists play a vital role in screening for these cancers through procedures like colonoscopies and endoscopies.